Simulations Plus, Inc. (Nasdaq: SLP), the leading provider of modeling and simulation solutions for the pharmaceutical, biotechnology, chemicals, and consumer goods industries, today announced that it has received notice from the U.S. Food and Drug Administration (FDA) that it has been awarded a new funded cooperative agreement, for $250,000 per year for up to two […]
System integrates phenotypic and genomic information at massive scale to define heterogeneity in cell populations, accelerate research, drug discovery and drug development DURHAM, N.C.–Celldom, Inc. today announced that it has been awarded a $1.5 million Phase II Small Business Innovation Research (SBIR) grant by the National Institutes of Health’s National Institute of General Medical Sciences […]
Former Chief Operations Officer and Delta™ System developer Ariel Notcovich promoted to drive industry adoption of the company’s core biomolecule characterization platform SOUTH SAN FRANCISCO, Calif. – Biodesy, Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel G. Notcovich to Chief Executive Officer, and the completion of a $20 million Series C financing. […]
Burlingame, California — Collaborative Drug Discovery, provider of CDD Vault web-based drug discovery informatics platform, announced they won a competitive, peer reviewed Phase 1 SBIR grant from NIH NCATS titled: “Digital representation of chemical mixtures to aid drug discovery and formulation”. InChI provides a concise, canonical, and unique summary of a compound rather than a […]
ORLANDO, FLA – Hesperos, Inc. announced today the receipt of a $4 million three-year NIH Phase IIb Small Business Innovation Research (SBIR) grant from the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to increase capacity for its novel human-on-a-chip technology, and prepare its systems for regulatory approval utilizing advanced PKPD […]
Pullach, September 4th, 2018 – As part of its Horizon 2020 research and innovation program, the European Union has agreed to support the high-tech start-up FreshDetect GmbH headquartered in Pullach, Germany (Munich). The grant is intended to help the company expand its BFD-100, a portable device for rapid and precise quality control of food products, across […]
Forges Partnership with Veritas Genetics to Accelerate Creation of Trusted Marketplace for Genomic Data as a Foundation for Data-Driven Medicine SAN FRANCISCO & BOSTON–Nebula Genomics announced today that it has raised $4.3M million in seed financing with participation from 10 leading venture capital firms. The funds will support the company’s mission to usher in the […]
BOULDER, Colo.–MBio Diagnostics, Inc., a company leading a new era in rapid, on-the-spot clinical diagnostics and sample testing, announced an additional $6 million in Series B financing led by new and existing investors, including MBio’s recently announced strategic veterinary partner, Heska. The funding supports the refinement of the MBio platform and improvements in manufacturing as […]
Recombinetics, a pioneer in gene-editing solutions for human health and animal agriculture, today announced the completion of a $34 million Series A financing round. “We’re pleased to announce the successful completion of our Series A Round,” said Tammy Lee, President and CEO of Recombinetics. “This financing will allow us to accelerate commercialization of this transformative science to […]
NEW YORK — Spheryx, Inc. announced today that the National Science Foundation (NSF) has awarded the company a Phase II-B Small Business Innovation Research (SBIR) grant for $500,000 over 2 years. This new grant is a continuation of an earlier grant entitled “Total Holographic Characterization of Colloids Through Holographic Video Microscopy” and is for the […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
